Suntar Eco-City Ltd
SGX:BKZ
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
SG |
S
|
Suntar Eco-City Ltd
SGX:BKZ
|
5m SGD | 0.8 | |
US |
Mckesson Corp
NYSE:MCK
|
72.5B USD | 0.2 | ||
US |
Cencora Inc
NYSE:COR
|
44.1B USD | 0.2 | ||
US |
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 0.1 | ||
US |
Cardinal Health Inc
NYSE:CAH
|
23.6B USD | 0.1 | ||
US |
Henry Schein Inc
NASDAQ:HSIC
|
9.4B USD | 0.8 | ||
KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | |
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
66.9B HKD | 0.1 | ||
IT |
Amplifon SpA
MIL:AMP
|
7.5B EUR | 3.3 | ||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
57.5B CNY | 1.4 | ||
CN |
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
52B CNY | 0.2 |
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.